In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rapamycin,Sirolimus,Rapamune Drug Master File in Korea (Rapamycin,Sirolimus,Rapamune KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rapamycin,Sirolimus,Rapamune. The MFDS reviews the Rapamycin,Sirolimus,Rapamune KDMF as part of the drug registration process and uses the information provided in the Rapamycin,Sirolimus,Rapamune KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rapamycin,Sirolimus,Rapamune KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rapamycin,Sirolimus,Rapamune API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rapamycin,Sirolimus,Rapamune suppliers with KDMF on PharmaCompass.